The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasutomo, K.
Right arrow Articles by Germain, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasutomo, K.
Right arrow Articles by Germain, R. N.
The Journal of Immunology, 00, 165: 3015-3022.
Copyright © 00 by The American Association of Immunologists

TCR Signaling for Initiation and Completion of Thymocyte Positive Selection Has Distinct Requirements for Ligand Quality and Presenting Cell Type

Koji Yasutomo1,*, Bruno Lucas*,{dagger} and Ronald N. Germain2,*

* Lymphocyte Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and {dagger} Institut National de la Santé et de la Recherche Médicale, Unité 345, Institut Necker, Paris, France

Thymocyte selection involves signaling by TCR engaging diverse self-peptide:MHC molecule ligands on various cell types in the cortex and medulla. Here we separately analyze early and late stages of selection to better understand how presenting cell type, ligand quality, and the timing of TCR signaling contribute to intrathymic differentiation. TCR transgenic CD4+CD8+ thymocytes (double positive (DP)) from MHC-deficient mice were stimulated using various presenting cells and ligands. The resulting CD69high cells were isolated and evaluated for maturation in reaggregate cultures with wild-type or MHC molecule-deficient thymic stroma with or without added hemopoietic dendritic cells (DC). Production of CD4+ T cells required TCR signaling in the reaggregates, indicating that transient recognition of self-ligands by DP is inadequate for full differentiation. DC bearing a potent agonist ligand could initiate positive selection, producing activated thymocytes that matured into agonist-responsive T cells in reaggregates lacking the same ligand. DC could also support the TCR signaling necessary for late maturation. These results argue that despite the negative role assigned to DC in past studies, neither the peptide:MHC molecule complexes present on DC nor any other signals provided by these cells stimulate only thymocyte death. These findings also indicate that unique epithelial ligands are not necessary for positive selection. They provide additional insight into the role of ligand quality in selection events and support the concept that following initiation of maturation from the DP state, persistent TCR signaling is characteristic of and perhaps required by T cells.




This article has been cited by other articles:


Home page
BloodHome page
U. Tomaru, A. Ishizu, S. Murata, Y. Miyatake, S. Suzuki, S. Takahashi, T. Kazamaki, J. Ohara, T. Baba, S. Iwasaki, et al.
Exclusive expression of proteasome subunit {beta}5t in the human thymic cortex
Blood, May 21, 2009; 113(21): 5186 - 5191.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
Y. Kuwano, C. M. Prazma, N. Yazawa, R. Watanabe, N. Ishiura, A. Kumanogoh, H. Okochi, K. Tamaki, M. Fujimoto, and T. F. Tedder
CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells
Int. Immunol., August 1, 2007; 19(8): 977 - 992.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Kao and P. M. Allen
An antagonist peptide mediates positive selection and CD4 lineage commitment of MHC class II-restricted T cells in the absence of CD4
J. Exp. Med., January 3, 2005; 201(1): 149 - 158.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. A. Baldwin, K. A. Hogquist, and S. C. Jameson
The Fourth Way? Harnessing Aggressive Tendencies in the Thymus
J. Immunol., December 1, 2004; 173(11): 6515 - 6520.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. R. Santori and S. Vukmanovic
Delineation of Signals Required for Thymocyte Positive Selection
J. Immunol., November 1, 2004; 173(9): 5517 - 5523.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Cannarile, N. Decanis, J. P. M. van Meerwijk, and T. Brocker
The Role of Dendritic Cells in Selection of Classical and Nonclassical CD8+ T Cells In Vivo
J. Immunol., October 15, 2004; 173(8): 4799 - 4805.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
S. Efroni, D. Harel, and I. R. Cohen
Toward Rigorous Comprehension of Biological Complexity: Modeling, Execution, and Visualization of Thymic T-Cell Maturation
Genome Res., November 1, 2003; 13(11): 2485 - 2497.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Louis, G. Dulude, S. Corneau, S. Brochu, C. Boileau, C. Meunier, C. Cote, N. Labrecque, and C. Perreault
Changes in the lymph node microenvironment induced by oncostatin M
Blood, August 15, 2003; 102(4): 1397 - 1404.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
X. Liu, A. Adams, K. F. Wildt, B. Aronow, L. Feigenbaum, and R. Bosselut
Restricting Zap70 Expression to CD4+CD8+ Thymocytes Reveals a T Cell Receptor-dependent Proofreading Mechanism Controlling the Completion of Positive Selection
J. Exp. Med., February 3, 2003; 197(3): 363 - 373.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. Kraj, R. Pacholczyk, H. Ignatowicz, P. Kisielow, P. Jensen, and L. Ignatowicz
Positive Selection of Cd4+ T Cells Is Induced in Vivo by Agonist and Inhibited by Antagonist Peptides
J. Exp. Med., August 20, 2001; 194(4): 407 - 416.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.